{"id":"https://openalex.org/W2074470137","doi":"https://doi.org/10.1111/j.2042-7158.1979.tb13651.x","title":"Monoamine oxidase inhibition and brain amine metabolism after oral treatment with toloxatone in the rat","display_name":"Monoamine oxidase inhibition and brain amine metabolism after oral treatment with toloxatone in the rat","publication_year":1979,"publication_date":"1979-09-01","ids":{"openalex":"https://openalex.org/W2074470137","doi":"https://doi.org/10.1111/j.2042-7158.1979.tb13651.x","mag":"2074470137","pmid":"https://pubmed.ncbi.nlm.nih.gov/41906"},"language":"en","primary_location":{"id":"doi:10.1111/j.2042-7158.1979.tb13651.x","doi":"https://doi.org/10.1111/j.2042-7158.1979.tb13651.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.2042-7158.1979.tb13651.x","pdf_url":null,"source":{"id":"https://openalex.org/S118304455","display_name":"Journal of Pharmacy and Pharmacology","issn_l":"0022-3573","issn":["0022-3573","2042-7158"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacy and Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103426010","display_name":"Peter E. Keane","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P E Keane","raw_affiliation_strings":["Centre de Recherche Delalande , 10, rue des Carri\u00e8res, 92500 Rueil-Malmaison,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre de Recherche Delalande , 10, rue des Carri\u00e8res, 92500 Rueil-Malmaison,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111552823","display_name":"J.P. Kan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J P Kan","raw_affiliation_strings":["Centre de Recherche Delalande , 10, rue des Carri\u00e8res, 92500 Rueil-Malmaison,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre de Recherche Delalande , 10, rue des Carri\u00e8res, 92500 Rueil-Malmaison,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064136749","display_name":"Nicole Sontag","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N Sontag","raw_affiliation_strings":["Centre de Recherche Delalande , 10, rue des Carri\u00e8res, 92500 Rueil-Malmaison,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre de Recherche Delalande , 10, rue des Carri\u00e8res, 92500 Rueil-Malmaison,","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5003140724","display_name":"Margherita Strolin Benedetti","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"M Strolin Benedetti","raw_affiliation_strings":["Centre de Recherche Delalande , 10, rue des Carri\u00e8res, 92500 Rueil-Malmaison,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre de Recherche Delalande , 10, rue des Carri\u00e8res, 92500 Rueil-Malmaison,","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5003140724"],"corresponding_institution_ids":[],"apc_list":{"value":2911,"currency":"GBP","value_usd":3839},"apc_paid":null,"fwci":0.6332,"has_fulltext":false,"cited_by_count":18,"citation_normalized_percentile":{"value":0.60923623,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"31","issue":"1","first_page":"752","last_page":"754"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.5166000127792358,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.5166000127792358,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.2782999873161316,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.04470000043511391,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/monoamine-oxidase-inhibition","display_name":"monoamine oxidase inhibition","score":0.9679999947547913},{"id":"https://openalex.org/keywords/monoamine-oxidase-a","display_name":"monoamine oxidase A","score":0.75},{"id":"https://openalex.org/keywords/monoamine-oxidase-b","display_name":"monoamine oxidase B","score":0.9980000257492065},{"id":"https://openalex.org/keywords/norepinephrine","display_name":"norepinephrine","score":0.9900000095367432},{"id":"https://openalex.org/keywords/dopamine","display_name":"dopamine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/serotonin","display_name":"serotonin","score":0.8920000195503235},{"id":"https://openalex.org/keywords/catecholamine-metabolites","display_name":"catecholamine metabolites","score":0.8270000219345093},{"id":"https://openalex.org/keywords/reversible-inhibition","display_name":"reversible inhibition","score":0.453000009059906},{"id":"https://openalex.org/keywords/antidepressants","display_name":"antidepressants","score":0.40299999713897705}],"concepts":[{"id":"https://openalex.org/C2776024655","wikidata":"https://www.wikidata.org/wiki/Q410867","display_name":"Monoamine oxidase","level":3,"score":0.8902251720428467},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.7939735651016235},{"id":"https://openalex.org/C2777477808","wikidata":"https://www.wikidata.org/wiki/Q407595","display_name":"Metabolite","level":2,"score":0.7865551114082336},{"id":"https://openalex.org/C2778377861","wikidata":"https://www.wikidata.org/wiki/Q424455","display_name":"Biogenic amine","level":4,"score":0.6645389795303345},{"id":"https://openalex.org/C187714386","wikidata":"https://www.wikidata.org/wiki/Q420225","display_name":"Monoamine neurotransmitter","level":4,"score":0.6242561340332031},{"id":"https://openalex.org/C62231903","wikidata":"https://www.wikidata.org/wiki/Q1057","display_name":"Metabolism","level":2,"score":0.5631030201911926},{"id":"https://openalex.org/C39398028","wikidata":"https://www.wikidata.org/wiki/Q18028862","display_name":"Monoamine oxidase B","level":4,"score":0.5563586354255676},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5527061820030212},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.5429167747497559},{"id":"https://openalex.org/C2778514916","wikidata":"https://www.wikidata.org/wiki/Q186242","display_name":"Norepinephrine","level":3,"score":0.482045978307724},{"id":"https://openalex.org/C131779359","wikidata":"https://www.wikidata.org/wiki/Q471875","display_name":"Amine gas treating","level":2,"score":0.4766136705875397},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4382937252521515},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.41210633516311646},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4081226587295532},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2802807688713074},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.27339857816696167},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.20405209064483643},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.05118924379348755},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001679","descriptor_name":"Biogenic Amines","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000648","qualifier_name":"ultrastructure","is_major_topic":false},{"descriptor_ui":"D003641","descriptor_name":"Deamination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004298","descriptor_name":"Dopamine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008996","descriptor_name":"Monoamine Oxidase Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D009638","descriptor_name":"Norepinephrine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D010080","descriptor_name":"Oxazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D010084","descriptor_name":"Oxidation-Reduction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012701","descriptor_name":"Serotonin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D013574","descriptor_name":"Synaptosomes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D023303","descriptor_name":"Oxazolidinones","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.2042-7158.1979.tb13651.x","doi":"https://doi.org/10.1111/j.2042-7158.1979.tb13651.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.2042-7158.1979.tb13651.x","pdf_url":null,"source":{"id":"https://openalex.org/S118304455","display_name":"Journal of Pharmacy and Pharmacology","issn_l":"0022-3573","issn":["0022-3573","2042-7158"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacy and Pharmacology","raw_type":"journal-article"},{"id":"pmid:41906","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/41906","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of pharmacy and pharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9476000070571899}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":21,"referenced_works":["https://openalex.org/W1598486575","https://openalex.org/W1910733505","https://openalex.org/W1934646281","https://openalex.org/W1983667689","https://openalex.org/W1985533494","https://openalex.org/W1987540547","https://openalex.org/W1990784490","https://openalex.org/W1993150017","https://openalex.org/W1995837298","https://openalex.org/W2002597738","https://openalex.org/W2019042502","https://openalex.org/W2033887285","https://openalex.org/W2040331724","https://openalex.org/W2042918192","https://openalex.org/W2051254875","https://openalex.org/W2081678546","https://openalex.org/W2087962260","https://openalex.org/W2152571675","https://openalex.org/W2284777263","https://openalex.org/W2755501813","https://openalex.org/W6929699960"],"related_works":["https://openalex.org/W1983565182","https://openalex.org/W2045521122","https://openalex.org/W2066163123","https://openalex.org/W2415530420","https://openalex.org/W2051254875","https://openalex.org/W4407013167","https://openalex.org/W3121101614","https://openalex.org/W2069183388","https://openalex.org/W11015559","https://openalex.org/W2043270340"],"abstract_inverted_index":{"Rats":[0],"were":[1,41,49,57],"administered":[2],"toloxatone":[3],"100":[4],"mg":[5],"kg-1":[6],"p.o.,":[7],"and":[8,39],"killed":[9],"0.5":[10],"to":[11],"8":[12],"hours":[13],"later.":[14],"Toloxatone":[15],"reversibly":[16],"inhibited":[17],"type":[18,28],"A":[19],"MAO,":[20],"but":[21],"did":[22],"not":[23,58],"affect":[24],"the":[25],"activity":[26],"of":[27,36,54],"B":[29],"MAO":[30],"in":[31],"whole":[32],"brain.":[33],"Cerebral":[34],"concentrations":[35,48],"noradrenaline,":[37],"dopamine":[38],"5-hydroxytryptamine":[40],"increased":[42],"after":[43],"toloxatone,":[44],"while":[45],"their":[46],"metabolite":[47],"reduced.":[50],"Synaptosomal":[51],"uptake":[52],"processes":[53],"these":[55],"amines":[56],"altered":[59],"by":[60],"tolaxatone.":[61]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}